Trials / Conditions / Warm Antibody Autoimmune Hemolytic Anemia
Warm Antibody Autoimmune Hemolytic Anemia
5 registered clinical trials studyying Warm Antibody Autoimmune Hemolytic Anemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia NCT05535933 | Hutchison Medipharma Limited | Phase 2 / Phase 3 |
| Active Not Recruiting | Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic NCT04657094 | City of Hope Medical Center | Phase 2 |
| Enrolling By Invitation | A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hem NCT04138927 | Rigel Pharmaceuticals | Phase 3 |
| Completed | A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the T NCT03764618 | Rigel Pharmaceuticals | Phase 3 |
| Completed | A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) NCT02612558 | Rigel Pharmaceuticals | Phase 2 |